최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.33 no.6, 2023년, pp.523 - 529
Ubiquitination is a post-translational modification that is involved in the quality control of proteins and responsible for modulating a variety of cellular physiological processes. Protein ubiquitination and deubiquitination are reversible processes that regulate the stability of target substrates....
Ayesha, A. K., Hyodo, T., Asano, E., Sato, N., Mansour,?M. A., Ito, S., Hamaguchi, M. and Senga, T. 2016. UBE2S?is associated with malignant characteristics of breast can- cer cells. Tumour Biol. 37, 763-772.
Ba, C., Ni, X., Yu, J., Zou, G. and Zhu, H. 2020. Ubiquitin?conjugating enzyme E2 M promotes apoptosis in osteo- arthritis chondrocytes via Wnt/beta-catenin signaling. Bio- chem. Biophys. Res. Commun. 529, 970-976.
Ben-Eliezer, I., Pomerantz, Y., Galiani, D., Nevo, N. and?Dekel, N. 2015. Appropriate expression of Ube2C and?Ube2S controls the progression of the first meiotic divi- sion. FASEB J. 29, 4670-4681.
Cai, F., Chen, P., Chen, L., Biskup, E., Liu, Y., Chen, P.?C., Chang, J. F., Jiang, W., Jing, Y., Chen, Y., Jin, H. and?Chen, S. 2014. Human RAD6 promotes G1-S transition?and cell proliferation through upregulation of cyclin D1?expression. PLoS One 9, e113727.
Ceccarelli, D. F., Tang, X., Pelletier, B., Orlicky, S., Xie,?W., Plantevin, V., Neculai, D., Chou, Y. C., Ogunjimi, A.,?Al-Hakim, A., Varelas, X., Koszela, J., Wasney, G. A.,?Vedadi, M., Dhe-Paganon, S., Cox, S., Xu, S., Lopez-Girona, A., Mercurio, F., Wrana, J., Durocher, D., Melo- che, S., Webb, D. R., Tyers, M. and Sicheri, F. 2011. An?allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme. Cell 145, 1075-1087.
Chondrogianni, N., Petropoulos, I., Grimm, S., Georgila,?K., Catalgol, B., Friguet, B., Grune, T. and Gonos, E. S.?2014. Protein damage, repair and proteolysis. Mol. Aspects?Med. 35, 1-71.
Ciechanover, A. 2013. Intracellular protein degradation:?from a vague idea through the lysosome and the ubiquitinproteasome system and onto human diseases and drug?targeting. Bioorg. Med. Chem. 21, 3400-3410.
Della Sala, G., Agriesti, F., Mazzoccoli, C., Tataranni, T.,?Costantino, V. and Piccoli, C. 2018. Clogging the ubiquitin-proteasome machinery with marine natural products:?last decade update. Mar. Drugs 16, 467.
Dikic, I., Wakatsuki, S. and Walters, K. J. 2009. Ubiquitin-binding domains - from structures to functions. Nat.?Rev. Mol. Cell Biol. 10, 659-671.
Gong, Y. Q., Peng, D., Ning, X. H., Yang, X. Y., Li, X.?S., Zhou, L. Q. and Guo, Y. L. 2016. UBE2T silencing?suppresses proliferation and induces cell cycle arrest and?apoptosis in bladder cancer cells. Oncol. Lett. 12, 4485-4492.
Grabbe, C., Husnjak, K. and Dikic, I. 2011. The spatial?and temporal organization of ubiquitin networks. Nat. Rev.?Mol. Cell Biol. 12, 295-307.
Hattori, T., Isobe, T., Abe, K., Kikuchi, H., Kitagawa, K.,?Oda, T., Uchida, C. and Kitagawa, M. 2007. Pirh2 pro- motes ubiquitin-dependent degradation of the cyclin-de- pendent kinase inhibitor p27Kip1. Cancer Res. 67, 10789-10795.
Hoege, C., Pfander, B., Moldovan, G. L., Pyrowolakis, G.?and Jentsch, S. 2002. RAD6-dependent DNA repair is?linked to modification of PCNA by ubiquitin and SUMO.?Nature 419, 135-141.
Hosseini, S. M., Okoye, I., Chaleshtari, M. G., Hazhirkar- zar, B., Mohamadnejad, J., Azizi, G., Hojjat-Farsangi, M.,?Mohammadi, H., Shotorbani, S. S. and Jadidi-Niaragh, F.?2019. E2 ubiquitin-conjugating enzymes in cancer: Impli- cations for immunotherapeutic interventions. Clin. Chim.?Acta 498, 126-134.
Hsu, S. H., Chen, S. H., Kuo, C. C. and Chang, J. Y. 2018.?Ubiquitin-conjugating enzyme E2 B regulates the ubiquiti- nation of O(6)-methylguanine-DNA methyltransferase and?BCNU sensitivity in human nasopharyngeal carcinoma?cells. Biochem. Pharmacol. 158, 327-338.
Jesenberger, V. and Jentsch, S. 2002. Deadly encounter:?ubiquitin meets apoptosis. Nat. Rev. Mol. Cell Biol. 3, 112-121.
Kothayer, H., Spencer, S. M., Tripathi, K., Westwell, A.?D. and Palle, K. 2016. Synthesis and in vitro anticancer?evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohy- drazides as Rad6 ubiquitin conjugating enzyme inhibitors.?Bioorg. Med. Chem. Lett. 26, 2030-2034.
Li, H., Niu, H., Peng, Y., Wang, J. and He, P. 2013. Ubc9?promotes invasion and metastasis of lung cancer cells.?Oncol. Rep. 29, 1588-1594.
Lin, D., Tatham, M. H., Yu, B., Kim, S., Hay, R. T. and?Chen, Y. 2002. Identification of a substrate recognition?site on Ubc9. J. Biol. Chem. 277, 21740-21748.
Liu, Q., Shang, F., Whitcomb, E., Guo, W., Li, W. and?Taylor, A. 2006. Ubiquitin-conjugating enzyme 3 delays?human lens epithelial cells in metaphase. Invest. Ophthal- mol. Vis. Sci. 47, 1302-1309.
Machida, Y. J., Machida, Y., Chen, Y., Gurtan, A. M., Kupfer, G. M., D'Andrea, A. D. and Dutta, A. 2006. UBE2T?is the E2 in the Fanconi anemia pathway and undergoes?negative autoregulation. Mol. Cell 23, 589-596.
Mittal, M. K., Singh, K., Misra, S. and Chaudhuri, G. 2011.?SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination. J. Biol.?Chem. 286, 469-479.
Mo, Y. Y., Yu, Y., Theodosiou, E., Ee, P. L. and Beck, W.?T. 2005. A role for Ubc9 in tumorigenesis. Oncogene 24, 2677-2683.
Notenboom, V., Hibbert, R. G., van Rossum-Fikkert, S.?E., Olsen, J. V., Mann, M. and Sixma, T. K. 2007. Functio- nal characterization of Rad18 domains for Rad6, ubiquitin,?DNA binding and PCNA modification. Nucleic Acids Res.?35, 5819-5830.
Osborne, H. C., Irving, E., Forment, J. V. and Schmidt,?C. K. 2021. E2 enzymes in genome stability: pulling the?strings behind the scenes. Trends Cell Biol. 31, 628-643.
Pal, A., Young, M. A. and Donato, N. J. 2014. Emerging?potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer. Cancer Res. 74, 4955-4966.
Pan, Y. H., Yang, M., Liu, L. P., Wu, D. C., Li, M. Y.?and Su, S. G. 2018. UBE2S enhances the ubiquitination?of p53 and exerts oncogenic activities in hepatocellular?carcinoma. Biochem. Biophys. Res. Commun 503, 895-902.
Pierce, N. W., Lee, J. E., Liu, X., Sweredoski, M. J.,?Graham, R. L., Larimore, E. A., Rome, M., Zheng, N.,?Clurman, B. E., Hess, S., Shan, S. O. and Deshaies, R.?J. 2013. Cand1 promotes assembly of new SCF complexes?through dynamic exchange of F box proteins. Cell 153, 206-215.
Pulvino, M., Liang, Y., Oleksyn, D., DeRan, M., Van Pelt,?E., Shapiro, J., Sanz, I., Chen, L. and Zhao, J. 2012. Inhibition of proliferation and survival of diffuse large B-cell?lymphoma cells by a small-molecule inhibitor of the ubiq- uitin-conjugating enzyme Ubc13-Uev1A. Blood 120, 1668-1677.
Rickman, K. A., Lach, F. P., Abhyankar, A., Donovan, F.?X., Sanborn, E. M., Kennedy, J. A., Sougnez, C., Gabriel,?S. B., Elemento, O., Chandrasekharappa, S. C., Schindler, D., Auerbach, A. D. and Smogorzewska, A. 2015. Defi- ciency of UBE2T, the E2 ubiquitin ligase necessary for?FANCD2 and FANCI ubiquitination, causes FA-T subtype?of fanconi anemia. Cell Rep. 12, 35-41.
Stewart, M. D., Ritterhoff, T., Klevit, R. E. and Brzovic,?P. S. 2016. E2 enzymes: more than just middle men. Cell?Res. 26, 423-440.
Streich, F. C. Jr. and Lima, C. D. 2014. Structural and?functional insights to ubiquitin-like protein conjugation.?Annu. Rev. Biophys. 43, 357-379.
Sun, X. X., Challagundla, K. B. and Dai, M. S. 2012.?Positive regulation of p53 stability and activity by the deu- biquitinating enzyme Otubain 1. EMBO J. 31, 576-592.
Torres-Ramos, C. A., Prakash, S. and Prakash, L. 2002.?Requirement of RAD5 and MMS2 for postreplication re- pair of UV-damaged DNA in Saccharomyces cerevisiae.?Mol. Cell Biol. 22, 2419-2426.
Tsukamoto, S., Takeuchi, T., Rotinsulu, H., Mangindaan,?R. E., van Soest, R. W., Ukai, K., Kobayashi, H., Nami- koshi, M., Ohta, T. and Yokosawa, H. 2008. Leucettamol?A: a new inhibitor of Ubc13-Uev1A interaction isolated?from a marine sponge, Leucetta aff. microrhaphis. Bioorg.?Med. Chem. Lett. 18, 6319-6320.
Ushiyama, S., Umaoka, H., Kato, H., Suwa, Y., Morioka,?H., Rotinsulu, H., Losung, F., Mangindaan, R. E., de Voogd,?N. J., Yokosawa, H. and Tsukamoto, S. 2012. Manadoster- ols A and B, sulfonated sterol dimers inhibiting the Ubc13-Uev1A interaction, isolated from the marine sponge Lisso- dendryx fibrosa. J. Nat. Prod. 75, 1495-1499.
Walker, A., Acquaviva, C., Matsusaka, T., Koop, L. and?Pines, J. 2008. UbcH10 has a rate-limiting role in G1?phase but might not act in the spindle checkpoint or as part of an autonomous oscillator. J. Cell Sci. 121, 2319-2326.
Wang, H., Zhang, C., Rorick, A., Wu, D., Chiu, M., Tho- mas-Ahner, J., Chen, Z., Chen, H., Clinton, S. K., Chan,?K. K. and Wang, Q. 2011. CCI-779 inhibits cell-cycle?G2-M progression and invasion of castration-resistant?prostate cancer via attenuation of UBE2C transcription and?mRNA stability. Cancer Res. 71, 4866-4876.
Wang, P., Li, Y., Ma, Y., Zhang, X., Li, Z., Yu, W., Zhu,?M., Wang, J., Xu, Y. and Xu, A. 2021. Comprehensive?investigation into the role of ubiquitin-conjugating enzyme?E2S in melanoma development. J. Invest. Dermatol. 141, 374-384.
Whitcomb, E. A., Tsai, Y. C., Basappa, J., Liu, K., Le?Feuvre, A. K., Weissman, A. M. and Taylor, A. 2019.?Stabilization of p27(Kip1)/CDKN1B by UBCH7/UBE2L3?catalyzed ubiquitinylation: a new paradigm in cell-cycle?control. FASEB J. 33, 1235-1247.
Xu, Y., Zhang, Z., Li, J., Tong, J., Cao, B., Taylor, P., Tang,?X., Wu, D., Moran, M. F., Zeng, Y. and Mao, X. 2017.?The ubiquitin-conjugating enzyme UBE2O modulates?c-Maf stability and induces myeloma cell apoptosis. J.?Hematol. Oncol. 10, 132.
Yang, H., Wu, L., Ke, S., Wang, W., Yang, L., Gao, X.,?Fang, H., Yu, H., Zhong, Y., Xie, C., Zhou, F. and Zhou,?Y. 2016. Downregulation of ubiquitin-conjugating enzyme?UBE2D3 promotes telomere maintenance and radioresist- ance of Eca-109 human esophageal carcinoma cells. J.?Cancer 7, 1152-1162.
Ye, Y. and Rape, M. 2009. Building ubiquitin chains: E2?enzymes at work. Nat. Rev. Mol. Cell Biol. 10, 755-764.
Yoon, H., Kim, M., Jang, K., Shin, M., Besser, A., Xiao,?X., Zhao, D., Wander, S. A., Briegel, K., Morey, L., Minn,?A. and Slingerland, J. M. 2019. p27 transcriptionally cor- egulates cJun to drive programs of tumor progression.?Proc. Natl. Acad. Sci. USA. 116, 7005-7014.
Zhou, C., Bi, F., Yuan, J., Yang, F. and Sun, S. 2018. Gain?of UBE2D1 facilitates hepatocellular carcinoma progres- sion and is associated with DNA damage caused by continuous IL-6. J. Exp. Clin. Cancer Res. 37, 290.
Zhou, Y., Chen, R., Luo, X., Zhang, W. D. and Qin, J. J.?2020. The E2 ubiquitin-conjugating enzyme UbcH5c: an emerging target in cancer and immune disorders. Drug?Discov. Today 25, 1988-1997.
Zou, T. and Lin, Z. 2021. The involvement of ubiquitination machinery in cell cycle regulation and cancer progres- sion. Int. J. Mol. Sci. 22, 5754.?
※ AI-Helper는 부적절한 답변을 할 수 있습니다.